| 发明名称 |
COMBINATION THERAPY OF A TYPE II ANTI-CD20 ANTIBODY WITH AN ANTI-BCL-2 ACTIVE AGENT. |
| 摘要 |
<p>The present invention is directed to the use of a type II anti-CD20 antibody for the manufacture of a medicament for the treatment of cancer, especially of CD20 expressing cancers in combination with an anti-Bcl-2 active agent.</p> |
| 申请公布号 |
MX2010003815(A) |
申请公布日期 |
2010.08.04 |
| 申请号 |
MX20100003815 |
申请日期 |
2008.10.13 |
| 申请人 |
ROCHE GLYCART AG |
发明人 |
PABLO UMANA;THOMAS FRIESS;CHRISTIAN KLEIN;PAMELA BRAEMER |
| 分类号 |
A61K39/395;A61P35/00 |
主分类号 |
A61K39/395 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
